logo
Select company
Select metric
-1232.49%Operating Cash Flow Margin
VS
Market
4
Sector
17
Industry
32
History
50
$ 5.8Close
$ 4.78 - $ 13.59 52-Week Range
Ticker Information

Ticker

BOLT

Company Name

BOLT BIOTHERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

BOLT BIOTHERAPEUTICS INC - Operating Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BOLT - OCF % Historical data
DateNet Cash Flow - OperationsOperating Cash Flow MarginRevenues
6/30/2025$ -51.36M-1232.49%$ 4.17M
3/31/2025$ -57.9M-1591.62%$ 3.64M
12/31/2024$ -61.29M-797%$ 7.69M
9/30/2024$ -61.12M-625.05%$ 9.78M
6/30/2024$ -63.91M-572.34%$ 11.17M
3/31/2024$ -62.88M-555.25%$ 11.32M
12/31/2023$ -69.53M-882.75%$ 7.88M
9/30/2023$ -73.21M-1017.12%$ 7.2M
6/30/2023$ -69.91M-1030.88%$ 6.78M
3/31/2023$ -75.59M-1121.17%$ 6.74M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • BOLT BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) OCF % stands at -20479.65%.
  • Over the past 5 years, BOLT BIOTHERAPEUTICS INC's average OCF % has been -2927.65%.
  • The median OCF % for BOLT BIOTHERAPEUTICS INC during this period was -1232.49%
  • BOLT BIOTHERAPEUTICS INC reached its highest OCF % over the past 5 years at -555.25%.
  • The lowest OCF % recorded by BOLT BIOTHERAPEUTICS INC in the same timeframe -20479.65%

BOLT BIOTHERAPEUTICS INC's OCF % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

OCF % Benchmarks
CompanyOCF %
TRAW : TRAWS PHARMA INC -927.73%CYCN : CYCLERION THERAPEUTICS INC -130.04%LPCN : LIPOCINE INC -118.5%INM : INMED PHARMACEUTICALS INC -157.14%LGVN : LONGEVERON INC -699.95%NBY : NOVABAY PHARMACEUTICALS INC -154.69%MRKR : MARKER THERAPEUTICS INC -202%APRE : APREA THERAPEUTICS INC -1514.98%LYRA : LYRA THERAPEUTICS INC -5585.32%INBS : INTELLIGENT BIO SOLUTIONS INC -250.1%

Definition of Operating Cash Flow Margin

[Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
CF - Operations / Revenues
(=) OCF %
OCF % for BOLT BIOTHERAPEUTICS INC is calculated as follows: CF - Operations [ $ -47.31M ] / Revenues [ $ 231K ]
(=) OCF % [ -20479.65% ]

BOLT - Operating Cash Flow Margin, Last 5 years

-20479.65%

Minimum

Dec 31, 2020

-555.25%

Maximum

Mar 31, 2024

-2927.65%

Average

-1232.49%

Median

OCF % Benchmark Analysis

The chart above depicts the distribution of OCF % for companies in the Total Stock Market. The average OCF % of the companies is 14.35% with a standard deviation of 21.14%.
The following table provides additional summary stats:
OCF % in the Market:
filtered constituents3.25K
min-57.27%
max78.12%
average14.35%
median12.67%
std21.14%